Arbennek Healthcare Limited 13863674 false 2022-01-21 2023-03-31 2023-03-31 The principal activity of the company is provision of staff to a Primary Care Network. Digita Accounts Production Advanced 6.30.9574.0 true 13863674 2022-01-21 2023-03-31 13863674 2023-03-31 13863674 bus:OrdinaryShareClass1 2023-03-31 13863674 core:CurrentFinancialInstruments 2023-03-31 13863674 core:CurrentFinancialInstruments core:WithinOneYear 2023-03-31 13863674 bus:SmallEntities 2022-01-21 2023-03-31 13863674 bus:AuditExemptWithAccountantsReport 2022-01-21 2023-03-31 13863674 bus:FullAccounts 2022-01-21 2023-03-31 13863674 bus:SmallCompaniesRegimeForAccounts 2022-01-21 2023-03-31 13863674 bus:RegisteredOffice 2022-01-21 2023-03-31 13863674 bus:Director3 2022-01-21 2023-03-31 13863674 bus:OrdinaryShareClass1 2022-01-21 2023-03-31 13863674 bus:PrivateLimitedCompanyLtd 2022-01-21 2023-03-31 13863674 bus:Agent1 2022-01-21 2023-03-31 13863674 countries:EnglandWales 2022-01-21 2023-03-31 iso4217:GBP xbrli:pure xbrli:shares

Arbennek Healthcare Limited

Annual Report and Unaudited Financial Statements
Period from 21 January 2022 to 31 March 2023

Registration number: 13863674

 

Arbennek Healthcare Limited

Contents

Balance Sheet

1 to 2

Notes to the Unaudited Financial Statements

3 to 5

Accountants' Report

6

 

Arbennek Healthcare Limited

Balance Sheet

31 March 2023

Note

2023
£

Current assets

 

Debtors

4

117,327

Cash at bank and in hand

 

90,898

 

208,225

Creditors: Amounts falling due within one year

5

(207,825)

Net assets

 

400

Capital and reserves

 

Called up share capital

6

400

Shareholders' funds

 

400

 

Arbennek Healthcare Limited

Balance Sheet

31 March 2023

For the financial period ending 31 March 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and the option not to file the Profit and Loss Account has been taken.

Approved and authorised by the Board on 17 January 2024 and signed on its behalf by:
 

.........................................
Dr R S Murthy
Director

Company Registration Number: 13863674

 

Arbennek Healthcare Limited

Notes to the Unaudited Financial Statements

Period from 21 January 2022 to 31 March 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
The Clays Practice
Victoria Road
Roche
Cornwall
PL26 8JF

These financial statements were authorised for issue by the Board on 17 January 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Income received in respect of the provision of staff is recongised as and when the services are provided to the end user.

Turnover comprises the fair value of the consideration received or receivable for the reimbursements of staff costs.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

 

Arbennek Healthcare Limited

Notes to the Unaudited Financial Statements

Period from 21 January 2022 to 31 March 2023

Financial instruments

Classification
The company holds the following financial instruments:

• Short term trade and other debtors and creditors;
• Cash and bank balances.

All financial instruments are classified as basic.

 Recognition and measurement
The company has chosen to apply the recognition and measurement principles in FRS102.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument and derecognised when in the case of assets, the contractual rights to cash flows from the assets expire or substantially all the risks and rewards of ownership are transferred to another party, or in the case of liabilities, when the company’s obligations are discharged, expire or are cancelled.

Except for bank loans, such instruments are initially measured at transaction price, including transaction costs, and are subsequently carried at the undiscounted amount of the cash or other consideration expected to be paid or received, after taking account of impairment adjustments.

Bank loans are initially measured at transaction price, including transaction costs, and are subsequently carried at amortised cost using the effective interest method.


 

3

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 12.

4

Debtors

2023
£

Trade debtors

117,189

Prepayments

138

117,327

 

Arbennek Healthcare Limited

Notes to the Unaudited Financial Statements

Period from 21 January 2022 to 31 March 2023

5

Creditors

Creditors: amounts falling due within one year

2023
£

Due within one year

Trade creditors

61

Taxation and social security

8,774

Other creditors

197,190

Accruals and deferred income

1,800

207,825

6

Share capital

Allotted, called up and fully paid shares

 

2023

 

No.

£

Ordinary of £1 each

400

400

     


Ordinary share capital

During the year the company issued 400 ordinary shares with a nominal value of £1 and a total value of £400.

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Arbennek Healthcare Limited

Period Ended 31 March 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Arbennek Healthcare Limited for the period ended 31 March 2023 as set out on pages 1 to 5 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Arbennek Healthcare Limited, as a body, in accordance with the terms of our engagement letter dated 14 August 2023. Our work has been undertaken solely to prepare for your approval the accounts of Arbennek Healthcare Limited and state those matters that we have agreed to state to the Board of Directors of Arbennek Healthcare Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Arbennek Healthcare Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Arbennek Healthcare Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Arbennek Healthcare Limited. You consider that Arbennek Healthcare Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the accounts of Arbennek Healthcare Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

PKF Francis Clark
Unit 18,23 Melville Building East
Royal William Yard
Stonehouse
Plymouth
PL1 3GW

17 January 2024